Korro Bio
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,292 | $1,090 |
Gross Profit | -380 | 643 | 1,090 | |
EBITDA | -19,745 | -20,056 | -15,234 | -16,882 |
EBIT | -20,110 | -20,436 | -15,883 | -18,061 |
Net Income | -18,916 | -19,625 | -50,042 | -18,061 |
Net Change In Cash | 0 | 0 | 1,292 | 1,090 |
Free Cash Flow | -17,030 | -16,095 | -17,786 | -17,354 |
Cash | 24,905 | 61,697 | 21,824 | 25,155 |
Basic Shares | 17,618 | 11,598 | 9,395 | 9,391 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $6,392 | $2,271 | $0 | $0 |
Gross Profit | 2,112 | 2,271 | -3,630 | -2,511 |
EBITDA | -83,062 | -88,345 | -80,904 | -56,487 |
EBIT | -87,342 | -91,910 | -84,534 | -58,998 |
Net Income | -117,260 | -83,581 | -81,172 | -58,032 |
Net Change In Cash | 6,392 | 2,271 | 0 | 0 |
Free Cash Flow | -79,079 | -77,976 | -75,119 | -58,857 |
Cash | 21,824 | 55,643 | 166,150 | 36,936 |
Basic Shares | 9,395 | 8,920 | 1,529 | 255 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$1.07 |
2026-03-31 | -$1.69 |
2025-12-31 | -$1.65 |
2025-09-30 | -$1.92 |